Plasma Cell Leukaemia

Authors

  • DR.DAPHNE FONSECA Department of Laboratory MedicineBasavatarakam Indo-American Cancer Hospital and Research Institute,Hyderabad
  • DR.FAIQ AHMED .Department of Laboratory MedicineBasavatarakam Indo-American Cancer Hospital and Research Institute,Hyderabad
  • DR.SUDHA MURTHY Department of Laboratory MedicineBasavatarakam Indo-American Cancer Hospital and Research Institute,Hyderabad
  • DR.SENTHIL RAJAPPA Department of Medical Oncology, Basavatarakam Indo-American Cancer Hospital and Research Institute,Hyderabad

Keywords:

plasma cell leukaemia, multiple myeloma,immunophenotyping

Abstract

Primary plasma cell leukemia (PCL) is a rare plasma cell disorder, and current knowledge regarding survival in this disease is limited to small series of patients. Although there has been significant improvement in the survival of patients with multiple myeloma (MM) over the past few decades, it is not known whether there has been a similar trend for PCL. The incidence of adverse prognostic factors is significantly higher in PCL versus MM. Although similar,PCL exhibits distinct clinical,immunophenotypic and cytogenetic features that distinguish it from MM.We report  three cases of Plasma cell leukaemia of which one was a primary plasma cell leukaemia and the other two cases were secondary plasma cell leukaemias.

Published

30.09.2012

How to Cite

DR.DAPHNE FONSECA, DR.FAIQ AHMED, DR.SUDHA MURTHY, & DR.SENTHIL RAJAPPA. (2012). Plasma Cell Leukaemia. International Journal of Pharma and Bio Sciences, 3(3), 476–481. Retrieved from https://ijpbs.net/index.php/journal/article/view/1578

Issue

Section

Case Reports

Categories